NCT07141563 2026-01-07
A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC
Bristol-Myers Squibb
Completed
Bristol-Myers Squibb
Hunan Province Tumor Hospital
Yuhan Corporation
Incyte Corporation
Hoffmann-La Roche
West Japan Thoracic Oncology Group